All > Rheumatoid Arthritis > Ra

Diet 2 for Rheumatoid Arthritis

UCSD, La Jolla, CA
Rheumatoid ArthritisDiet 2 - Other
Eligibility
18+
All Sexes

Study Summary

This trial will study whether an anti-inflammatory diet can improve clinical outcomes in people with rheumatoid arthritis, as well as the role of the microbiome and circulating metabolites.

Eligible Conditions
  • Rheumatoid Arthritis

Treatment Effectiveness

Phase-Based Effectiveness

1 of 3
N/A

Similar Trials

1
Early Tocilizumab
1
200mg Cannabidiol by capsules twice daily
1
2-HOBA

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: 3 months

3 months
Decrease of more than 5 points in Clinical Disease Activity Index

Trial Safety

Phase-Based Safety

1 of 3

Similar Trials

2
Early Tocilizumab
1
200mg Cannabidiol by capsules twice daily
2
2-HOBA

Side Effects for

Acetaminophen
63%Acute uri
61%Fever
26%Allergic rhinitis
25%Otitis media NOS
21%Cough
11%Strep sore throat
11%Vomiting
9%Headache
7%Diarrhea
7%Wheezing
3%asthma exacerbation
1%Pneumonia
1%Simple laceration
This histogram enumerates side effects from a completed 2015 Phase 3 trial (NCT01606319) in the Acetaminophen ARM group. Side effects include: Acute uri with 63%, Fever with 61%, Allergic rhinitis with 26%, Otitis media NOS with 25%, Cough with 21%.

Awards & Highlights

No Placebo Group
All patients enrolled in this trial will receive the new treatment.

Trial Design

2 Treatment Groups

Arm_1
1 of 2
Arm_2
1 of 2

Active Control

Experimental Treatment

124 Total Participants · 2 Treatment Groups

Primary Treatment: Diet 2 · No Placebo Group · N/A

Arm_2
Other
Experimental Group · 1 Intervention: Diet 2 · Intervention Types: Other
Arm_1
Other
ActiveComparator Group · 1 Intervention: Diet 1 · Intervention Types: Other

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 3 months

Who is running the clinical trial?

University of California, San DiegoLead Sponsor
1,051 Previous Clinical Trials
1,826,783 Total Patients Enrolled
7 Trials studying Rheumatoid Arthritis
2,215 Patients Enrolled for Rheumatoid Arthritis

Eligibility Criteria

Age 18+ · All Participants · 1 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You have mild or moderate symptoms of the condition being studied, and have not had any changes in treatment or symptoms for the last 3 months. You are willing to try a new diet and can attend all follow-up appointments.
References

Frequently Asked Questions

Are there any limitations to how many participants can take part in this clinical trial?

"Yes, clinicaltrials.gov affirms that this trial is actively seeking participants. This experiment was initially published on November 1st 2020 and the latest update occurred on July 19th 2022. The researchers are hoping to find 124 patients across a single study location." - Anonymous Online Contributor

Unverified Answer

Can any new applicants join this clinical research study?

"Yes, the information recorded on clinicaltrials.gov affirms that this medical study is actively accepting new patients. It was first uploaded to the website on November 1st 2020 and last modified on July 19th 2022. A total of 124 participants are being sought from a single centre." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top